Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan

BACKGROUND: Pyrazinamide (PZA) is an important first-line drug in multidrug-resistant tuberculosis (MDRTB) treatment. However, the unreliable results obtained from traditional susceptibility testing limits its usefulness in clinical settings. The detection of pncA gene mutations is a potential surro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chiu, Yu-Chi, Huang , Shiang-Fen, Yu, Kwok-Woon, Lee, Yu-Chin, Feng, Jia-Yih, Su, Wei-Juin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3180675/
https://ncbi.nlm.nih.gov/pubmed/21910892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-240
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak